Furthermore, we demonstrate that SETDB1 promotes HCC cell proliferation, migration, chemoresistance and tumorigenesis in vivo by activating AKT via methylating on the K64 site. This evidence concerns the gene SETDB1 and hepatocellular carcinoma.